CORDIS
EU research results

CORDIS

English EN
Ethics of enhancement technology

Ethics of enhancement technology

Objective

The main objective of this ETHENTECH project is to take substantially further forward both the ethical evaluation and public discussion of two important emerging fields of micro- and nanobiotechnology which pose very significant ethical and societal issues of public concern: neurological implants and the potential for human functional enhancement. Neural implants are a major new class of medical devices, which create an interface between nerve tissues and nano- or micro-scale probes. The aim is to enable a patient’s nervous system to communicate with new devices that replace or supplement a malfunctioning organ, for example to restore hearing or eyesight or to treat degenerative diseases like Parkinson’s. Human functional enhancement technology refers to a wide range of converging technologies which have the potential to enable significant modification of the systems of the human body, beyond what might be seen as medical purposes. The subjects of the ETHENTECH project address some of the most far-reaching fields among new and emerging technologies today - in terms of their potential social impact and the challenges these will pose to ethical issues and values of European citizens and societies. The project’s two fields of implant and human enhancement technologies both lack ethical frameworks and European and international guidelines. This absence reflects the emerging and complex nature of both areas. They also represent cases where issues of dual use are a significant and further complicating factor. While several EC and other projects have given useful overviews of the ethical terrain, it is clear that there is now a pressing need to engage in more depth with particular issues in order to focus ethical frameworks and guidelines around particular issues.

Coordinator

KUNGLIGA TEKNISKA HOEGSKOLAN

Address

Brinellvagen 8
100 44 Stockholm

Sweden

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 252 646

Administrative Contact

Pehr Halse (Mr.)

Participants (4)

Sort alphabetically

Sort by EU Contribution

Expand all

EDINETHICS LIMITED

United Kingdom

EU Contribution

€ 191 526

CAMBRIDGE BIOMEDICAL CONSULTANTS LIMITED

United Kingdom

EU Contribution

€ 24 265

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU Contribution

€ 6 000

New Economics Foundation

United Kingdom

EU Contribution

€ 25 452

Project information

Grant agreement ID: 230361

Status

Closed project

  • Start date

    1 July 2009

  • End date

    30 June 2012

Funded under:

FP7-SIS

  • Overall budget:

    € 667 321

  • EU contribution

    € 499 889

Coordinated by:

KUNGLIGA TEKNISKA HOEGSKOLAN

Sweden